Biotech

New licensing deal adds fresh buzz to joint venture

By GREGORY ZELLER // A partnership between a Stony Brook biotech and a Canadian pharmaceutical-solutions provider is growing like a weed. Less than a year since introducing the world’s first DNA-based cannabis-tagging system and just five months since they upgraded the system to accommodate large-scale growers, Applied DNA Sciences and Canadian/Panamanian cohort TheraCann International Benchmark Corp. have inked an exclusive licensing deal. The skinny: a long-term licensing agreement pairing Applied DNA’s proprietary CertainT supply chain…

Read More

In Applied DNA’s new UL partnership, it’s safety first

By GREGORY ZELLER // A new deal with a worldwide safe-sciences leader will expand a Long Island innovator’s already-impressive global reach. Illinois-based UL, known primarily as Underwriters Laboratories for most of its 124-year history, has reached a “commercial agreement” with Applied DNA Sciences that will “lay the foundation for a significant new development in product authentication and supply-chain traceability,” according to a statement from Applied DNA. Financial terms were not disclosed, but the partnership will…


At FSC, skin-deep startup joins Start-Up NY’s ranks

By GREGORY ZELLER // The Empire State Development Corp. has opened its books and welcomed another Long Island company into the Start-Up NY family. Farmingdale State College announced this week that startup biotech BF Innovation, which moved into FSC’s Broad Hollow Bioscience Park earlier this year, has been accepted into the Start-Up NY program, which boosts new and expanding businesses with tax breaks and innovative academic partnerships. BF Innovation plans to invest $1 million and…


Albany backs NYIT’s next-gen bioengineering lab

By GREGORY ZELLER // A new bioengineering laboratory is coming to the New York Institute of Technology’s Old Westbury campus, thanks to a hefty state award. The Empire State Development Corp. on Wednesday announced a $150,000 grant that will help NYIT establish the Bio-Nanotechnology and Biomaterials Laboratory, a research- and innovation-focused bioengineering lab packed with next-level tech facilitating specialized research into complex bioengineering, artificial-intelligence and life-sciences issues. The grant was awarded through Round 7 of…


SBU joins elite HHS business-development task force

By GREGORY ZELLER // Stony Brook University will join an elite roster of national institutions in a new business-development feeder system devised by the U.S. Department of Health & Human Services. Introduced Tuesday as a business-accelerator program under the auspices of BARDA, HHS’s Biomedical Advanced Research and Development Authority, the nationwide network will foster development of new “health security” protocols – that is, preparedness to respond to threats ranging from chemical attacks and radiological terrorism…


Feinstein ‘risk index’ could get the jump on lupus

By GREGORY ZELLER // A complex research effort led by top Feinstein Institute scientists has opened the door to a wide range of early-intervention protocols for the dreaded disease lupus. A Feinstein Institute for Medical Research team led by immunologist and Professor Betty Diamond has developed a system for identifying a person’s risk for lupus by examining antibodies and a specific protein complex found in the blood. Ideally, scientists may use these unique markers to…


Envisagenics’ artificial intelligence wows real investors

By GREGORY ZELLER // They’re on a major roll at Envisagenics Inc., a Cold Spring Harbor Laboratory spinoff that’s piling up some hefty research grants. Now based in New York City, the biotech announced this week that it’s been awarded a $1.5 million Small Business Innovation Research Phase II grant from the National Institutes of Health – the second time the NIH has backed the data-crunching startup. The new award is earmarked for the continued…